 |
autologous lymphocytes depleted ex vivo of immunoreactive T cells using 4,5 |
|---|---|
| Trade Name | Theralux Photodynamic Therapy |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2008-04-03 00:00:00 |
| Sponsor | Kiadis Pharma Canada, Inc.;2525 Marie Curie; |
